MARKETS
PERPS
LIVE
58
PRO
NEW
MORE
Cash
Portfolio
Log in
Sign up
Trending
Elections
Politics
Culture
Sports
Crypto
Commodities
Climate
Economics
Mentions
Finance
Tech & Science
Predict
Live
58
Account
Search
Social
Trending
Elections
Politics
Culture
Sports
Crypto
Commodities
Climate
Economics
Mentions
Finance
Tech & Science
Industries
Trending
Frequency
All markets
Public Companies Hub
Companies
Indices
Industries
Biotech
Compute
Markets
Industries
NVIDIA RTX 5090 · Hourly price on Aug 14 (Week 33)
Above $0.50
1.52
x
64
%
Above $0.55
8.56
x
6
%
$72,626 vol
17 markets
Industries
NVIDIA A100 · Hourly price on Aug 14 (Week 33)
Above $1.00
1.20
x
87
%
Above $1.25
23.4
x
2
%
$52,828 vol
10 markets
Industries
NVIDIA H200 · Hourly price on Aug 14 (Week 33)
Above $4.50
2.05
x
12
%
Above $5.50
31.2
x
1
%
$56,145 vol
11 markets
Industries
NVIDIA B200 · Hourly price on Aug 14 (Week 33)
Above $6.00
7.25
x
8
%
Above $5.50
1.12
x
91
%
$43,035 vol
13 markets
Industries
NVIDIA H100 · Hourly price on Aug 14 (Week 33)
Above $2.75
1.55
x
29
%
Above $3.00
23.4
x
2
%
$36,646 vol
12 markets
Industries
NVIDIA RTX 5090 · Average hourly price in August
Above $0.50
1.97
x
1
%
Above $1.00
46.8
x
2
%
$40,753 vol
8 markets
Industries
NVIDIA H100 · Average hourly price in August
Above $2.75
3.52
x
25
%
Above $2.50
1.05
x
80
%
$14,078 vol
9 markets
Industries
NVIDIA A100 · Average hourly price in August
Above $1.00
1.10
x
83
%
Above $1.50
46.8
x
1
%
$33,663 vol
7 markets
Industries
NVIDIA H200 · Average hourly price in August
Above $4.50
1.50
x
56
%
Above $5.50
18.8
x
10
%
$92,924 vol
11 markets
Biotech
FDA decision: Iberdomide by BMS/Celgene (this year)
Yes
1.08
x
92
%
No
7.25
x
8
%
$5,948 vol
1 market
Industries
NVIDIA B200 · Average hourly price in August
Above $5.50
1.18
x
78
%
Above $6.00
1.52
x
26
%
$30,079 vol
9 markets
Biotech
FDA decision: Brepocitinib by Priovant Therapeutics (this year)
Yes
1.22
x
81
%
No
3.96
x
19
%
$2,482 vol
1 market
Biotech
FDA decision: Ivonescimab by Summit Therapeutics (this year)
Yes
1.52
x
64
%
No
2.29
x
36
%
$4,127 vol
1 market
Biotech
FDA decision: DTX401 (pariglasgene brecaparvovec) by Ultragenyx Pharmaceutical (this year)
Yes
1.18
x
69
%
No
2.66
x
31
%
$1,733 vol
1 market
Compute
DDR5 16Gb (2Gx8) 4800/5600 · Average price in August 2026
Above $52.00
1.73
x
45
%
Above $52.25
2.24
x
44
%
$1,084 vol
40 markets
Compute
DDR5 16Gb (2Gx8) eTT · Average price in August 2026
Above $23.60
1.52
x
62
%
Above $23.70
2.89
x
31
%
$5,649 vol
30 markets
Biotech
FDA decision: Venglustat by Sanofi (this year)
Yes
1.16
x
85
%
No
4.51
x
15
%
$452 vol
1 market
Industries
What will the price of TrendForce’s DDR5 be at year-end 2027?
Above $45.00
1.73
x
56
%
Above $55.00
2.40
x
39
%
$5,535 vol
9 markets
Biotech
FDA decision: Saroglitazar by Zydus Therapeutics (this year)
Yes
1.33
x
67
%
No
2.98
x
33
%
$351 vol
1 market
Biotech
FDA decision: Rusfertide by Protagonist Therapeutics (this year)
Yes
1.09
x
90
%
No
6.29
x
10
%
$1,640 vol
1 market
Biotech
FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (this year)
Yes
1.22
x
74
%
No
3.80
x
26
%
$468 vol
1 market
Compute
DDR5 16Gb (2Gx8) 4800/5600 · price on Aug 14 (Week 33)
Above $49.75
1.02
x
91
%
Above $50.00
1.02
x
91
%
$0 vol
20 markets
Compute
DDR5 16Gb (2Gx8) eTT · price on Aug 14 (Week 33)
Above $24.80
5.90
x
8
%
Above $24.70
5.56
x
9
%
$36 vol
20 markets
Biotech
FDA decision: bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN) by Gilead Sciences (this year)
Yes
1.04
x
85
%
No
8.56
x
15
%
$664 vol
1 market